News

The 2024 Health Hackathon brought together 185 students with diverse backgrounds from Cornell and 26 other universities—in just 36 hours, they addressed critical safety challenges facing patients today.

Individuals with physical health concerns made up the largest and fastest growing of five subgroups of individuals who died by suicide in the United States over roughly twenty years, according to an analysis led by Weill Cornell Medicine in collaboration with Columbia University, UC Berkeley School of Public Health, the University of Hong Kong and University of Kentucky investigators.

A team led by Dr. Samie Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a three-year, $1.65 million grant for RNA research under a biotechnology-development program run by the U.S. National Science Foundation.

For younger Black patients living in rural parts of the Southeastern United States, peer coaching is more effective than traditional clinical care in controlling high blood pressure, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. 

Researchers at Weill Cornell Medicine have performed the most comprehensive analysis to date of cancer of the ureters or the urine-collection cavities in the kidney, known as upper tract urothelial carcinoma (UTUC). 

Of the 109 Weill Cornell Medical College students graduating in May, 107 garnered residencies, with 87 percent of them matching to top postgraduate residency specialty programs.

Weill Cornell Medicine investigators discovered that unique bacteria colonize the gut shortly after birth and produce the neurotransmitter serotonin which educates gut immune cells and prevents food allergies.

Specialized nursing facility clinicians, or SNFists, may decrease the likelihood of nursing home residents experiencing stressful hospitalizations and improve the quality of life in their last days, according to researchers from Weill Cornell Medicine.

Rampant mistrust of medical science during the COVID-19 pandemic represents the rule, not the exception, of public perception of mainstream medicine over the last two centuries, said Lewis A. Grossman, a distinguished professor of law at American University’s Washington College of Law, in a lecture at Weill Cornell Medicine on March 13. 

Researchers at Weill Cornell Medicine have shown that three months of social worker follow-up support to people hospitalized with HIV in Tanzania had health benefits at low cost.

A new study found that retinoic acid receptors (RARa) in the proximal tubules of the kidney play a crucial role in limiting the damaging effects of kidney injury that often lead to kidney failure.

The program’s annual white coat ceremony celebrated the Class of 2026 and represented the start of the students’ new educational experience.

The 2024 Startup Symposium & InvestConnect Conference celebrated scientific inquiry and the entrepreneurial spirit.

Weill Cornell Medicine is part of an international team that has been awarded funding of up to $25 million over five years by Cancer Grand Challenges to study the causes of cancer inequities.

Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators.

Awards, honors and achievements for the month of February.

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine in New York and GHESKIO in Haiti.

A new study identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small cell lung cancer (NSCLC) treated with a combination of immunotherapy and low-dose radiation.

A Weill Cornell Medicine-led research team has been awarded a 2024 Top 10 Clinical Research Achievement Award from the Clinical Research Forum in recognition of an influential 2023 New England Journal of Medicine study on early-stage lung cancer resection.

Researchers at the Jill Roberts Center for IBD and the Jill Roberts Institute for Research in IBD at Weill Cornell Medicine and NewYork-Presbyterian have determined that sulfasalazine works by modulating the activity of a group of gut bacteria that are more abundant in patients who respond to the drug.